Evidence of a Gastro-Duodenal Effect on Adipose Tissue and Brain Metabolism, Potentially Mediated by Gut–Liver Inflammation: A Study with Positron Emission Tomography and Oral 18FDG in Mice
Authors:
- Maria Angela GuzzardiMGMaria Angela Guzzardi
- Federica La RosaFRFederica La Rosa
- Daniela CampaniDCDaniela Campani
- Andrea Cacciato InsillaAIAndrea Cacciato Insilla
- Monica NannipieriMNMonica Nannipieri
- Maurizia Rossana BrunettoMaurizia Rossana Brunetto
- Ferruccio BoninoFerruccio Bonino
- Patricia IozzoPIPatricia Iozzo
Open Access
- 28 February 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (5) , 2659
Abstract
Interventions affecting gastrointestinal (GI) physiology suggest that the GI tract plays an important role in modulating the uptake of ingested glucose by body tissues. We aimed at validating the use of positron emission tomography (PET) with oral 18FDG administration in mice, and to examine GI effects on glucose metabolism in adipose tissues, brain, heart, muscle, and liver, and interfering actions of oral lipid co-administration. We performed sequential whole-body PET studies in 3 groups of 10 mice, receiving i.p. glucose and 18FDG or oral glucose and 18FDG ± lipids, to measure tissue glucose uptake (GU) and GI transit, and compute the absorption lumped constant (LCa) as ratio of oral 18FDG-to-glucose incremental blood levels. GI and liver histology and circulating hormones were tested to generate explanatory hypothesis. Median LCa was 1.18, constant over time and not significantly affected by lipid co-ingestion. Compared to the i.p. route, the oral route (GI effect) resulted in lower GU rates in adipose tissues and brain, and a greater steatohepatitis score (+17%, p = 0.03). Lipid co-administration accelerated GI transit, in relation to the suppression in GIP, GLP1, glucagon, PP, and PYY (GI motility regulators), abolishing GI effects on subcutaneous fat GU. Duodenal crypt size, gastric wall 18FDG uptake, and macro-vesicular steatosis were inversely related to adipose tissue GU, and positively associated with liver GU. We conclude that 18FDG-PET is a suitable tool to examine the role of the GI tract on glucose transit, absorption, and bio-distribution. The GI effect consists in the suppression of glucose metabolism selectively in organs responsible for energy intake and storage, and is blunted by lipid ingestion. Modulation of gut and liver inflammation, as reflected by high GU, may be involved in the acute signalling of the energy status.Keywords
Funding Information
- JPI-HDHL-INTIMIC (GUTMOM-085 and MISVILUPPO-KP-778)
This publication has 32 references indexed in Scilit:
- Dynamic Observation of 18F-FDG Uptake After Oral Administration in a Healthy SubjectJournal of Nuclear Medicine Technology, 2013
- Blunted metabolic responses to cold and insulin stimulation in brown adipose tissue of obese humansObesity, 2013
- PET Imaging of the Gastrointestinal Absorption of Orally Administered Drugs in Conscious and Anesthetized RatsJournal of Nuclear Medicine, 2011
- Effects of GLP-1 and Incretin-Based Therapies on Gastrointestinal Motor FunctionExperimental Diabetes Research, 2011
- Inflammation Markers and Metabolic Characteristics of Subjects With 1-h Plasma Glucose LevelsDiabetes Care, 2009
- Separate Impact of Obesity and Glucose Tolerance on the Incretin Effect in Normal Subjects and Type 2 Diabetic PatientsDiabetes, 2008
- Substitution of Oral 18F-FDG for Intravenous 18F-FDG in PET ScanningJournal of Nuclear Medicine Technology, 2007
- Quantification of Liver Glucose Metabolism by Positron Emission Tomography: Validation Study in PigsGastroenterology, 2007
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005
- Human adipose tissue glucose uptake determined using [ 18 F]-fluoro-deoxy-glucose ([ 18 F]FDG) and PET in combination with microdialysisDiabetologia, 2001